P. Schulman

发表

High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.

R. Vij, R. Larson, W. Stock, 2011, Leukemia research.

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

D. Scheinberg, M. Kalaycio, K. Seiter, 2003, Leukemia.

Use of cisplatin for elderly patients.

D. Budman, M. Schuster, S. Allen, 1992, Age and ageing.

NO INCREASED RISK OF TAXOL TOXICITY IN OLDER PATIENTS

D. Budman, V. Vinciguerra, S. Lichtman, 1996, Journal of the American Geriatrics Society.

Treatment of Aggressive Non‐Hodgkin's Lymphoma in Elderly Patients With Thiotepa, Novantrone (Mitoxantrone), Vincristine, Prednisone (TNOP)

J. Kolitz, D. Budman, V. Vinciguerra, 2001, American journal of clinical oncology.

IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.

B. Diamond, M. Dono, V. Vinciguerra, 1994, Autoimmunity.

Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.

D. Budman, M. Schuster, S. Allen, 1991, Leukemia.

Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study.

L. Norton, A. Gottlieb, M. Barcos, 1990, Medical and pediatric oncology.

PROGENITORS OF CLL B CELLS 1593 incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients

N. Chiorazzi, M. Dono, M. Ferrarini, 2002 .

Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification.

P. Gregersen, N. Chiorazzi, M. Dono, 1996, Blood.

B Cell Chronic Lymphocytic Leukemia

N. Chiorazzi, K. Rai, M. Ferrarini, 2003 .

Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.

P. Gregersen, N. Chiorazzi, J. Kolitz, 1997, Journal of immunology.

Cytogenetic findings in the dysmyelopoietic syndrome

D. Budman, V. Vinciguerra, Jessica G. Davis, 1982, Cancer.

Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.

P. Gregersen, F. Batliwalla, N. Chiorazzi, 2000, Current topics in microbiology and immunology.

Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non–Hodgkin Lymphoma

A. Zelenetz, A. Iasonos, O. O’Connor, 2011, Clinical Cancer Research.

A study of lymphoma of large granular lymphocytes with modern modalities: Report of two cases and review of the literature

P. Koduru, M. Susin, J. Kolitz, 1992, American journal of hematology.

PRODUCTION OF AUTOANTIBODIES BY C135-EXPRESSING B LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHOCYTEC LEUKEMIA

N. Chiorazzi, D. Budman, V. Vinciguerra, 2003 .

Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer.

R. Wittes, N. Geller, G. Petroni, 1985, Cancer research.

Dysmyelopoietic syndrome. Current concepts.

D. Budman, L. Weiselberg, P. Schulman, 1984, The American journal of medicine.

Burkitt's leukemia: A re‐evaluation

D. Budman, V. Vinciguerra, S. Teichberg, 1982, Cancer.

Electron microscope cytochemical analysis of chronic myelocytic leukemia: A case report

D. Budman, V. Vinciguerra, S. Teichberg, 1981, Cancer.

A Dose Escalation and Phase II Study of Gemtuzumab Ozogamicin (GO) with High-Dose Cytarabine (HiDAC) for Patients (pts) with Refractory or Relapsed Acute Myeloid Leukemia (AML): CALGB 19902.

R. Larson, W. Stock, J. Kolitz, 2004 .

Acute agranular CD4‐positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents

W. C. Chan, P. Koduru, T. Loughran, 1995, Cancer.

Phase I evaluation of divided-dose vinblastine sulfate

D. Budman, V. Vinciguerra, P. Schulman, 2004, Cancer Chemotherapy and Pharmacology.

Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.

P. Koduru, M. Bar‐eli, M. Schuster, 1991, Blood.

Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.

P. Gregersen, N. Chiorazzi, M. Dono, 1996, The Journal of clinical investigation.

B-CELL ACTIVATION IN ANGIOIMMUNOBLASTIC LYMPHADENOPATHY AFTER IMMUNISATION WITH MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE

D. Budman, V. Vinciguerra, P. Schulman, 1979, The Lancet.

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

N. Chiorazzi, K. Rai, M. Ferrarini, 1999, Blood.

Biclonal lgM gammopathy in a lymphoproliferative disorder

H. Gerstein, M. Susin, D. Budman, 1983, Cancer.

Carmustine and myelodysplasia.

S. Lichtman, P. Schulman, 1985, Annals of internal medicine.

Monosomy 5 in acute megakaryoblastic leukemia. Report of two cases.

M. Susin, S. Lichtman, P. Schulman, 1988, Cancer genetics and cytogenetics.

A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemia.

J. Kolitz, D. Budman, V. Vinciguerra, 1981, Cancer genetics and cytogenetics.

Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days.

D. Budman, V. Vinciguerra, S. Allen, 1985, Cancer research.

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.

M. Caligiuri, C. Bloomfield, C. Croce, 1996, Cancer research.

Anaphylactoid reaction due to AZQ

D. Budman, V. Vinciguerra, L. Weiselberg, 1982, Cancer Chemotherapy and Pharmacology.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

R. Mayer, C. Schiffer, J. Moore, 1994, The New England journal of medicine.

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

R. Larson, R. Dodge, R. Stone, 1995, Blood.

Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours.

D. Budman, S. Allen, S. Lichtman, 1988, Cancer research.

Flow cytometry. A new technique in the diagnosis of malignant ascites.

D. Grueneberg, D. Budman, D R Budman, 1987, Journal of clinical gastroenterology.

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Edward J. Lee, C. Bloomfield, S. George, 2001, Blood.

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Stephen L. George, Edward J. Lee, S. George, 1995 .

Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.

H. Preisler, A. Gottlieb, H. Hoagland, 1987, Blood.

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

L. Rassenti, T. Kipps, N. Chiorazzi, 1998, The Journal of clinical investigation.

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

N. Chiorazzi, D. Budman, V. Vinciguerra, 1989, The Journal of experimental medicine.

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

Xiao-Jie Yan, N. Chiorazzi, K. Rai, 2002, Blood.

Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.

J. Kolitz, D. Budman, V. Vinciguerra, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acquired idiopathic sideroblastic anemia: a new chromosomal abnormality.

D. Budman, V. Vinciguerra, L. Weiselberg, 1983, Cancer genetics and cytogenetics.

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

Edward J. Lee, C. Bloomfield, R. Larson, 1998, Blood.

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.

B. Leyland-Jones, R. Mertelsmann, D. Budman, 1985, Cancer research.

Phenotypic and genotypic characterization of Hodgkin's disease

P. Koduru, M. Susin, P. Schulman, 1993, American journal of hematology.

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

D. Scheinberg, R. Stone, M. Kalaycio, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of monosomy 7 with myelodysplasia following chemotherapy for Hodgkin's disease: serial observations.

J. Kross, D. Budman, V. Vinciguerra, 1981, Cancer genetics and cytogenetics.

A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

B. Kasimis, W. Hahne, P. Schulman, 1997, Cancer investigation.

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

D. Budman, M. Schuster, S. Allen, 2004, Cancer Chemotherapy and Pharmacology.

Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders.

D. Heitjan, R. Mertelsmann, J. Kolitz, 1988, Blood.

Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells

N. Chiorazzi, M. Dono, M. Ferrarini, 1995, The Journal of experimental medicine.

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

S. George, R. Dodge, R. Stone, 1995, The New England journal of medicine.

Pancytopenia complicating Graves' disease and drug-induced hypothyroidism.

D. Budman, V. Vinciguerra, D. Margouleff, 1981, Archives of internal medicine.

Defect in Acute Myeloid Leukemia with Trisomy 11 as a Recurrent Molecular ALL 1 Partial Tandem Duplication of Updated

M. Caligiuri, C. Bloomfield, C. Croce, 2006 .

Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease

S. Jhanwar, A. Lesokhin, E. Riedel, 2012, Leukemia and Lymphoma.

Phase I trial of vinzolidine.

D. Budman, V. Vinciguerra, W. Kreis, 1984, Cancer treatment reports.

Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.

D. Budman, V. Vinciguerra, L. Weiselberg, 1981, Cancer clinical trials.

Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.

K. Rai, P. Koduru, J. Kolitz, 1996, Leukemia.

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Steven L. Allen, Fabio Ghiotto, N. Chiorazzi, 1999, Blood.

De novo disseminated intravascular coagulation in angioimmunoblastic lymphadenopathy (AILD)

D. Budman, V. Vinciguerra, P. Schulman, 1983, Cancer.

A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.

R. Warrell, P. O'dwyer, G. Heller, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study evaluating two dosing schedules of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) in patients with relapsed/refractory indolent and mantle cell lymphomas

A. Zelenetz, C. Moskowitz, O. O’Connor, 2008 .

Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis

P. Koduru, M. Bar‐eli, M. Schuster, 1991 .

Meningeal involvement in IgD myeloma with cerebrospinal fluid paraprotein analysis

M. Susin, V. Vinciguerra, L. Sharer, 1980, Cancer.

Extramedullary myeloma with metastatic features.

P. Schulman, D. Lake-Lewin, 1979, JAMA.

Low-Dose Ara-C by Continuous Infusion in the Treatment of Acute Non-Lymphocytic Leukemia (ANLL) and Myelodysplastic Syndrome (MDS)

D. Budman, V. Vinciguerra, S. Allen, 1986 .

B Cell Chronic Lymphocytic Leukemia

N. Chiorazzi, K. Rai, M. Ferrarini, 2003 .

Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.

D. Budman, V. Vinciguerra, L. Weiselberg, 1983, Cancer treatment reports.

Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.

D. Budman, V. Vinciguerra, L. Weiselberg, 1982, Cancer treatment reports.

Adjuvant Therapy of Stage II Breast Cancer Treated with CMFVP, Radiation Therapy and VATH Following Lumpectomy A Pilot Trial

D. Budman, V. Vinciguerra, S. Lichtman, 1991, American journal of clinical oncology.